SCLX (Scilex Holding) Sotuvning yalpi rentabelligi

Scilex Holding Company, Inc. (SCLX) kompaniyasining rasmiy ramzlari

Farmatsevtika logistikasi va aksiz qoidalarining qat'iy nazorati distribyutsiyani murakkablashtiradi, biroq opioid bo'lmagan analgetiklarga bo'lgan barqaror talab turg'un pul oqimini ta'minlaydi. Valo martaba trayektoriyasi ushbu bahsni hal qiladi, bunda 29.20 eng so'nggi metrika ko'rsatkichini ifodalaydi. Biroq, yuqori qarzlar va patent nizolari Scilex Holding Company (SCLX) moliyaviy barqarorligi uchun jiddiy xavflarni yuzaga keltirmoqda.

SCLX Scilex Holding Yalpi rentabellik (28.04.2023 - 20.11.2026)

Scilex Holding Company (SCLX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
- pul qoldiqlari va pul oqimlari ma'lumotlari:
Fundamental baholash:SCLX, Scilex Holding
Scilex Holding Company, Inc. original mahsuloti

Scilex Holding Company (SCLX) kompaniyasining kokainga asoslanmagan og'riq qoldiruvchi vositalariga bo'lgan barqaror talab biznesni makroiqtisodiy zarbalar va mavsumiy tebranishlarga chidamli qiladi. Valo martaba (gross margin) bevosita ishlab chiqarish xarajatlari qoplanganidan keyin qolgan daromad qismini o'lchaydi, bu esa investorlarga valo martaba tendentsiyasini operatsion samaradorlik va kapitalni himoya qilish ko'rsatkichi sifatida tahlil qilish orqali xarajatlarni boshqarish samaradorligini va emitentning narx belgilash imkoniyatlarini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)